This post was originally published on this site
The Arlington, Virginia-based company said it lowered the outlook to about $4 billion from around $6 billion, citing a potential impact from legislation requiring capitalization of research and experimentation expenses for tax purposes.
The company in July posted lower-than-expected second-quarter revenue, hurt by global supply chain issues that dented production at the aerospace and defense firm.
